These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36530641)

  • 1. CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review.
    Rinaldi V; Bellucci G; Buscarinu MC; Reniè R; Marrone A; Nasello M; Zancan V; Nistri R; Palumbo R; Salerno A; Salvetti M; Ristori G
    Front Neurol; 2022; 13():1018785. PubMed ID: 36530641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and the risk of CNS demyelinating diseases: A systematic review.
    Lotan I; Nishiyama S; Manzano GS; Lydston M; Levy M
    Front Neurol; 2022; 13():970383. PubMed ID: 36203986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD.
    Kim S; Seok HY
    Neurol Sci; 2023 Jun; 44(6):1841-1848. PubMed ID: 36781562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 infection after two doses of SARS-CoV-2 mRNA vaccine in multiple sclerosis, AQP4-antibody NMOSD and MOGAD.
    Yeo T; Quek AML; Yong KP; Tye JSN; Ratnagopal P; Soon DTL; Tan K
    Mult Scler Relat Disord; 2022 Sep; 65():104003. PubMed ID: 35803084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience.
    Monte G; Papetti L; Ferilli MAN; Ursitti F; Moavero R; Sforza G; Panella E; Tarantino S; Checchi MP; Vigevano F; Palma P; Valeriani M
    Front Immunol; 2023; 14():1106472. PubMed ID: 36761740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New onset or relapsing neuromyelitis optica temporally associated with SARS-CoV-2 infection and COVID-19 vaccination: a systematic review.
    Harel T; Gorman EF; Wallin MT
    Front Neurol; 2023; 14():1099758. PubMed ID: 37426444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Watch out for neuromyelitis optica spectrum disorder onset or clinical relapse after COVID-19 vaccination: What neurologists need to know?
    Paybast S; Emami A; Baghalha F; Naser Moghadasi A
    Mult Scler Relat Disord; 2022 Sep; 65():103960. PubMed ID: 35763914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNS demyelinating disease following inactivated or viral vector SARS-CoV-2 vaccines: A case series.
    Ebrahimi N; Mazdak M; Shaygannejad V; Mirmosayyeb O
    Vaccine; 2023 Jan; 41(5):1003-1008. PubMed ID: 36635139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of cases of CNS demyelination following COVID-19 vaccination.
    Ismail II; Salama S
    J Neuroimmunol; 2022 Jan; 362():577765. PubMed ID: 34839149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination - A self-controlled case series analysis.
    Morgan HJ; Clothier HJ; Sepulveda Kattan G; Boyd JH; Buttery JP
    Vaccine; 2024 Apr; 42(9):2212-2219. PubMed ID: 38350771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease.
    Li EC; Zheng Y; Cai MT; Lai QL; Fang GL; Du BQ; Shen CH; Zhang YX; Wu LJ; Ding MP
    Epilepsia; 2022 Sep; 63(9):2173-2191. PubMed ID: 35652436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kong L; Wang X; Chen H; Shi Z; Lang Y; Zhang Y; Zhou H
    Mult Scler Relat Disord; 2022 Dec; 68():104167. PubMed ID: 36170773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and COVID-19: A Systematic Review.
    Mirmosayyeb O; Ghaffary EM; Dehghan MS; Ghoshouni H; Bagherieh S; Barzegar M; Shaygannejad V
    J Cent Nerv Syst Dis; 2023; 15():11795735231167869. PubMed ID: 37008248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders.
    Sechi E; Krecke KN; Messina SA; Buciuc M; Pittock SJ; Chen JJ; Weinshenker BG; Lopez-Chiriboga AS; Lucchinetti CF; Zalewski NL; Tillema JM; Kunchok A; Monaco S; Morris PP; Fryer JP; Nguyen A; Greenwood T; Syc-Mazurek SB; Keegan BM; Flanagan EP
    Neurology; 2021 Sep; 97(11):e1097-e1109. PubMed ID: 34261784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report.
    Lohmann L; Glaser F; Möddel G; Lünemann JD; Wiendl H; Klotz L
    BMC Neurol; 2022 May; 22(1):185. PubMed ID: 35585528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
    Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
    Front Immunol; 2021; 12():653786. PubMed ID: 33981305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-Positive Neuromyelitis Optica Spectrum Disorder After Second COVID-19 Vaccination: a Case Report.
    Kuntz S; Saab G; Schneider R
    SN Compr Clin Med; 2022; 4(1):130. PubMed ID: 35761845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD.
    Dinoto A; Sechi E; Ferrari S; Gajofatto A; Orlandi R; Solla P; Maccabeo A; Maniscalco GT; Andreone V; Sartori A; Manganotti P; Rasia S; Capra R; Mancinelli CR; Mariotto S
    Mult Scler Relat Disord; 2022 Feb; 58():103424. PubMed ID: 35216793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
    Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
    J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.